Hans Brug new director-general RIVM Professor J. (Hans) Brug has been appointed director-general of RIVM per September 10, 2018.
No further spread of polio virus after contamination employee The employee of a Dutch vaccine manufacturer, who was infected with the polio virus in early April, is no longer carrying the virus.
Blood analysis local residents confirms longtime exposure to PFOA The results of blood analysis show that measured blood values correspond well with the calculated values in an earlier study in 2016 on the emission of perfluorooctanoic acid (PFOA) by DuPont/Chemo
HPV vaccination not only protects against cervical cancer HPV vaccination against cervical cancer also appears to protect against other forms of cancer that can be caused by HPV.
More knowledge required about environmental effect of GenX More knowledge is required about the extent to which GenX substances accumulate in fish.
Meningococcal immunisation recommendations re-examined Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.
Employee vaccine manufacturer infected with polio virus Early April, a sealed room at a vaccine manufacturer was the site of an incident. Two employees were exposed to the polio virus.
Chinese delegation at RIVM Xu Ke, Vice Minister National Health and Family Planning Commission of the People’s Republic of China, visited RIVM at its premises at Bilthoven on July 15th 2013.
Jaap van Dissel appointed as Director of the RIVM Centre for Infectious Disease Control Prof Jaap van Dissel is appointed as Director of the RIVM Centre for Infectious Disease Control. He takes up the post on 15 August and succeeds Prof.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr